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List of abbreviations 
AIRg: acute insulin response to glucose 
CGIT: combined glucose insulin tolerance test 
EHC: euglycaemic hyperinsulinaemic clamp 
EMS: equine metabolic syndrome 
FSIGTT: frequently sampled intravenous glucose tolerance test 
GIP: glucose-dependent insulinotropic peptide or gastric inhibitory peptide 
GLP-1: glucagon-like peptide-1 
HOMA-IS: homeostasis model assessment of insulin sensitivity 
IST: insulin sensitivity test 
IVGTT: intravenous glucose tolerance test 
MIRG: modified insulin to glucose ratio 
OGT: oral glucose test 
OST: oral sugar test 
QUICKI: quantitative insulin sensitivity check index 
RISQI: reciprocal inverse square of basal insulin 
Sg: glucose effectiveness 
SI: insulin sensitivity 
Si: insulin sensitivity index 
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T1/2: glucose half-life 
 
Summary 
Insulin dysregulation is the hallmark of Equine Metabolic Syndrome and has received attention 
because of its direct association with laminitis. In the absence of an adequate treatment for 
laminitis, a focus on prophylaxis is needed, making early detection of individuals at risk of 
developing laminitis one of the main challenges in equine endocrinology. Recent studies have 
shown that insulin dysregulation goes beyond tissue insulin resistance and it is now 
demonstrated that the equine enteroinsular axis plays a major role in insulin secretion and 
equine hyperinsulinaemia. In this review, we discuss the different tests currently available to 
diagnose insulin dysregulation in horses: the ones investigating tissue insulin resistance and the 
ones investigating the enteroinsular axis, detailing their goals, practicalities and limitations. 
This review supports the contention that the diagnosis of equine insulin dysregulation should 
now be based on the investigation of both tissue insulin resistance and the equine enteroinsular 
axis. Regardless of the tests used many factors of variation, such as breed, diet, fasting state or 
season, have been identified and could potentially confound the results of a specific test. 
Therefore, careful interpretation of the results of a given test in each individual situation is 
required to optimise the detection of horses at risk of laminitis. 
 
Introduction 
Equine Metabolic Syndrome (EMS) has been described as a medical condition that groups, 
insulin dysregulation, altered circulating adipokine concentrations, dyslipidaemia (with or 
without obesity) and a predisposition to laminitis [1; 2]. Although there is no universally 
accepted definition of equine obesity, it seems that the world population of overweight or obese 
horses is increasing and can reach, in some areas, a prevalence as high as 72.2% [3]. This 
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suggests that, in parallel with what is described in humans, obesity and/or regional adiposity, 
and its associated endocrine disorders will continue to be a major challenge for the equine 
industry [4-6]. 
 
The pathophysiology of EMS remains unclear. However, it has been shown that infusing insulin 
can trigger the development of laminitis in healthy horses establishing a link between 
hyperinsulinaemia and laminitis [7; 8]. The terms insulin dysregulation and insulin resistance 
have been used interchangeably; however, insulin dysregulation is a broader term as it 
encompasses both tissue insulin resistance and both persistent or intermittent 
hyperinsulinaemia [2]. Tissue insulin resistance is the inability of tissues to respond adequately 
to insulin, whereas hyperinsulinaemia is the circulation of an inappropriate amount of insulin 
after a given stimulus [9; 10]. Hyperinsulinaemia can be symptomatic of tissue insulin 
resistance when it occurs as a compensatory response to peripheral tissue insulin resistance. 
However, recent research on the equine enteroinsular axis has shown that horses can have an 
excessive insulin response to ingested carbohydrates (without concurrent tissue insulin 
resistance), which results in transient hyperinsulinaemia and demonstrates that 
hyperinsulinaemia can be present in the absence of tissue insulin resistance [11]. Therefore, 
tissue insulin resistance and hyperinsulinaemia may represent two different arms of a 
pathological process that can precipitate laminitis. 
 
 
The direct link between insulin and laminitis remains unknown and whether there is a local or 
systemic effect is unclear. Several studies have failed to implicate local tissue insulin resistance 
in laminitis development [12-14]. Some mechanisms to explain insulin-associated laminitis 
have been proposed, such as a mitogenic effect on the lamellar epithelial cells, obesity-induced 
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chronic inflammation resulting in neutrophil activation and proinflammatory cytokine 
production or vascular dysfunction resulting in hypoxia and endothelial activation [15-26]. 
However, more research is needed to elucidate the finer mechanisms of insulin-associated 
laminitis. 
 
Although laminitis has been a major burden on the equine industry for many years, no adequate 
treatment is available and the development of laminitis is still associated with decreased 
survival after one year of onset [27]. Horses with EMS may have pre-existing radiographic 
changes or abnormal growth rings on their hooves before the first recognised episode of 
laminitis [28]. Therefore, prevention of the first painful episode of laminitis is critical when 
managing horses with EMS. In order to be able to prevent the development of the first episode 
of laminitis, early detection of the horses at risk is necessary. 
 
As more pieces of the insulin dysregulation puzzle are put together, new tests are developed 
and the interpretation of older tests changes. The ideal test would be able to detect horses in the 
early stages of insulin dysregulation and would need to have strong intrinsic value considering 
that many environmental and individual factors have been shown to confound the results of any 
given test. In this review, we will detail the different diagnostic tests available for the 
identification of insulin dysregulation in horses, and consider their advantages and their limits. 
We will also discuss the confounding factors, and their effect on the interpretation of the tests. 
Diagnosis of insulin resistance 
The techniques used to assess the degree of tissue sensitivity to insulin in horses and ponies are 
mostly adapted from human medicine. While many of these tests have been available for some 
time they continue to be refined for use in the equine species. Further, our appreciation of the 
need for accurate, flexible and feasible tests is increasing. 
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Fasting blood glucose concentration 
Hyperglycaemia is an indirect measure of tissue insulin resistance. Horses can produce large 
quantities of insulin and rarely develop pancreatic exhaustion; therefore, hyperglycaemia 
suggests a defective compensatory insulin response and, if persistent, warrants investigation of 
diabetes mellitus [1; 7]. Although blood glucose concentration may be at the upper end of the 
reference range in horses with EMS, there are many other possible causes of hyperglycaemia, 
such as stress, feeding, drug administration or concurrent disease. Additionally, the length of 
fasting required to consider a sample as fasted is debatable. In studies investigating the effect of 
fasting on glucose dynamics the length of fast varies from 12 to 72 hours [29-32]. Thus, fasting 
blood glucose is a poor diagnostic test for tissue insulin resistance with both low specificity and 
low sensitivity [33-35]. 
 
Euglycaemic hyperinsulinaemic clamp 
The euglycaemic hyperinsulinaemic clamp (EHC) developed in 1974 by Sherwin et al. is still 
considered as the “gold standard” to diagnose tissue insulin resistance in human medicine [36; 
37]. This test, as described by Kronfeld et al., has also been considered as the “gold standard” for 
the diagnosis of tissue insulin resistance in horses [2; 35; 38; 39]. After a priming dose of 
insulin, the horse receives a continuous infusion of insulin (3 – 6 mIU/kg/min) and blood 
glucose is maintained at a constant value (around 5 mmol/L) by adjusting the glucose infusion 
rate [7; 35; 38]. At steady state, the glucose infusion rate (corrected to account for glucose that 
had been added or removed from glucose space other than by metabolism) provides the insulin-
induced glucose disposal rate. A low glucose infusion rate indicates tissue insulin resistance 
whereas a high glucose infusion rate indicates effective insulin-induced glucose disposal and 
insulin sensitivity [38]. Although this test provides a direct measurement of the ability of 
insulin-sensitive tissues to respond to exogenous insulin, the interpretation of this test may be 
difficult for a given horse in the absence of breed-specific reference ranges. For example, in a 
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general population of horses a value lower than 7 µmol/kg/min would indicate tissue insulin 
resistance but when only Dutch Warmbloods are considered a value lower than 14 
µmol/kg/min would indicate tissue insulin resistance [35]. Additionally, the EHC may be too 
extreme to reflect normal physiologic processes and because it requires several hours with 
adequate equipment and trained staff to reach a steady state, the use of the EHC may be limited 
to research settings [35]. Despite its practical issues, the EHC is often used as a reference to 
compare other tests to, and it is repeatable, with a coefficient of variation of 14% [38; 40]. 
 
Insulin sensitivity test 
The insulin sensitivity test (IST) directly assesses the ability of insulin-sensitive tissues, such as 
skeletal muscles, adipose tissue and liver, to take up glucose. Different versions of this test have 
been described, a complete test and a short test [41; 42]. The complete test, as described by 
Caltabilota et al. assesses insulin sensitivity by measuring blood glucose after intravenous 
injection of variable doses of insulin (20 – 125 mIU/kg) over 5 hours [41]. The short test (2-step 
test), as described by Bertin et al. assesses insulin sensitivity by measuring blood glucose 30 
minutes after intravenous injection of 100 mIU/kg of insulin [42]. For both tests, a 50% 
decrease in blood glucose indicates insulin sensitivity. The repeatability of the complete IST has 
been shown to be equal to, or better than, most currently used methods of assessing tissue 
insulin resistance in horses, with a coefficient of variation of 9% [41]. Additionally, the 
agreement between the complete and the short version of the tests has been shown to be 
excellent suggesting that the short version of the insulin tolerance test could be used in the field 
[42]. The test carries a small risk of inducing marked hypoglycaemia. However, clinical signs of 
hypoglycaemia rarely require treatment [43]. 
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Frequently sampled intravenous glucose tolerance test 
Two versions of the frequently sampled intravenous glucose tolerance test have been described. 
The first is based on an intravenous glucose injection (FSIGTT, sometimes called intravenous 
glucose tolerance test or IVGTT) and the other one consists of an intravenous glucose injection 
followed by intravenous insulin injection (modified FSIGTT). In the FSIGTT described by Pratt 
et al., 500 mg/kg of dextrose is injected and up to 36 blood samples are collected over 6 hours 
to measure glucose and insulin [38]. The computerised mathematical models used to describe 
the glucose and insulin responses to intravenous glucose injection (minimal model analysis and 
area under the glucose and insulin curves) allow the calculation of the insulin sensitivity index 
(Si, reflecting insulin-dependent glucose clearance), the glucose effectiveness (Sg, reflecting 
insulin-independent glucose clearance), the acute insulin response to glucose (AIRg, reflecting 
the glucose-induced insulin secretion or  cell responsiveness) and the glucose half-life (T1/2g, 
reflecting overall glucose clearance) [38]. This FSIGTT has been shown to have poor 
repeatability with a within-horse coefficient of variability between 24 and 30%, but to correlate 
well with the EHC [38; 40]. Some minor changes have been made to the test in order to limit 
glucose urinary spilling resulting in the injection of smaller doses of dextrose (100 – 300 
mg/kg) [44-47]. The modified FSIGTT, as described by Hoffman et al. or Bailey et al., differs 
from the FSIGTT by the intravenous injection of 20 – 30 mIU/kg of insulin 20 minutes after 
dextrose injection allowing the calculation of insulin sensitivity (SI, reflecting the efficiency of 
insulin to accelerate glucose uptake) [48; 49]. A diagnosis of tissue insulin resistance is made 
when SI is low (<1 L/min/mIU) whereas a horse is classified as insulin sensitive with a high SI 
(>1.5 L/min/mIU) [50]. This modified FSIGTT has been widely used in research settings and is 
often considered as a new “gold standard” for the assessment of tissue insulin resistance in 
horses [1; 40; 45; 50-54]. 
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Combined glucose insulin tolerance test 
The combined glucose insulin tolerance test (CGIT) was developed as a simplified combination 
of the IST and the FSIGTT. The CGIT, as described by Eiler et al., is based on the almost 
simultaneous intravenous injection of 150 mg/kg of dextrose and 100 mIU/kg of insulin [43]. 
Over 150 minutes, 14 blood samples are collected to measure glucose and insulin. The almost 
simultaneous injection of glucose and insulin results in a biphasic curve with a positive phase 
(relative hyperglycaemia) and a negative phase (relative hypoglycaemia). The interpretation of 
the test is either based on the duration of the positive phase (tissue insulin resistance if the 
relative hyperglycaemia lasts more than 45 min) or on the insulin concentration after 45 min 
(tissue insulin resistance if >100 µIU/mL), or both [43; 45; 55]. However, these cut-off values 
are yet to be fully validated in the horse. The repeatability of the test is similar to other tests 
with a coefficient of variation around 15%, with insulin data being more repeatable than 
glucose data [43]. However, using the duration of the positive phase, the sensitivity and 
specificity of the CGIT have been shown to be 85.7% and 40% respectively (using the FSIGTT as 
reference), and using the insulin value at 45 min, the sensitivity and specificity of the CGIT have 
been shown to be 28.5% and 100% respectively (using the FSIGTT as reference) [45]. 
 
Proxies and surrogate tests 
In order to simplify the diagnosis of tissue insulin resistance in horses, a few surrogate tests 
have been developed. These tests seem to be widely used in human medicine and are attractive 
to equine practitioners aiming to make a diagnosis of tissue insulin resistance based on limited 
tests in a field environment. However, it is important to remember that none of these tests have 
been fully validated in equine patients [56; 57]. In horses, the glucose/insulin ratio has been 
shown to be a good estimate of insulin sensitivity and the insulin/glucose ratio has been shown 
to correlate with insulin secretion as measured by the EHC [35]. A glucose/insulin ratio <10 
suggests insulin resistance whereas a glucose/insulin ratio <4.5 indicates severe or 
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decompensated insulin resistance [34]. However, in another study, this ratio failed to identify 
horses diagnosed as insulin resistant by other tests [29]. In a study by Kronefeld et al. the 
homeostasis model assessment of insulin sensitivity (HOMA-IS: 22.5/(glucose x insulin)) and 
the quantitative insulin sensitivity check index (QUICKI: 1/(log(glucose) + log(insulin)) 
correlated well with the results of the EHC [35] and in a study by Treiber et al., the reciprocal 
inverse square of basal insulin (RISQI: insulin-0.5) and the modified insulin to glucose ratio 
(MIRG: (800 – 0.3 (insulin – 50)2)/(glucose – 30)) correlated well with the SI and AIRg results of 
the modified FSIGTT in 46 healthy Thoroughbreds (coefficient of correlation of 0.774 and 0.754 
respectively) [58]. However, the total predictive values of the proxies in the assessment of 
insulin sensitivity in healthy horses was about 80% and whilst both proxies have a high 
specificity (85% using SI as a reference or 88% using AIRg as a reference), their sensitivity was 
low (45% using SI as a reference and 50% using AIRg as a reference) [58]. Unfortunately, very 
few studies have evaluated the relevance and the validity of these surrogate tests in equine 
diseases, which limits their potential clinical application [34]. 
 
Diagnosis of hyperinsulinaemia 
Basal serum insulin concentration 
Hyperinsulinaemia (>20 µIU/mL if fasted or >60 µIU/mL if fed) in the presence of clinical 
suspicion of EMS is supportive of insulin dysregulation and warrants the use of a dynamic test 
[1; 59; 60]. Conversely, a serum insulin concentration within the reference range (this varies 
slightly between laboratories) in the presence of clinical suspicion of EMS is non-diagnostic [1]. 
In a few studies, horses diagnosed with insulin dysregulation by other tests were not found to 
be hyperinsulinaemic, and when specifically compared to the FSIGTT, the sensitivity of basal 
serum insulin was 0% [45]. Although single point in time hyperinsulinaemia is not sensitive to 
diagnose insulin dysregulation, spontaneous hyperinsulinaemia is associated with the 
development of laminitis and decreased survival. In a group of horses suffering from 
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endocrinopathies, a basal serum insulin >188 µIU/mL had a sensitivity and a specificity >90% 
to predict laminitis and nonsurvival after one year [7]. In another study in horses with no 
history of laminitis, a basal serum insulin >21.8 µIU/mL had a sensitivity and a specificity >70% 
to predict the occurrence of laminitis within 3 years [3].  
 
Confounding the problems associated with the use of basal serum insulin concentration is the 
variety of laboratory assays currently used to determine equine insulin concentration [61-65]. 
All of the currently available tests suffer limitations and this is an area in desperate need of 
further research. 
 
Oral sugar test 
The oral sugar test (OST) investigates the glucose-induced insulin response to the oral 
administration of non-structural carbohydrates [46; 66]. A diagnosis of hyperinsulinaemia with 
the OST, as described by Schuver et al., is based on a serum insulin >60 µIU/mL 60 or 90 
minutes after oral administration of 0.15 mL/kg of corn syrup to horses fasted overnight [67]. 
This test measures the insulin response to an oral dose of carbohydrate and account for the 
enteroinsular axis [11]. The interpretation of the results of this test may be difficult as a few 
studies have found the test to have poor repeatability, with a coefficient of variation as high as 
40% [68; 69]. Additionally, when compared to the FSIGTT, the OST had a sensitivity of 0% 
which would tremendously limit the potential clinical value of the test if this value is correct 
[45]. 
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Oral glucose test 
In areas of the world where corn syrup is not as readily available, an oral glucose test (OGT) has 
been developed [70]. A diagnosis of hyperinsulinaemia with the OGT, as described by de Laat et 
al., is based on a serum insulin >80 µIU/mL 120 minutes after oral administration of 0.75 – 1 
g/kg of glucose [71]. The method of administration of glucose varies; in some studies, powdered 
dextrose is mixed with bran and/or chaff and spontaneously eaten by the horse and in others, 
glucose is administered through a nasogastric tube as a solution [40; 69]. Regardless of the 
method of administration, the OGT has better repeatability than the OST, with a coefficient of 
variability around 20% and the two tests agreed with respect to dichotomous outcome in 85% 
of cases [69; 71]. This test has also been shown to correlate with the results of the EHC and the 
modified FSIGTT in healthy Standardbreds [40]. The ease of this test, and the ability to 
accurately determine the dose of glucose administered (the glucose content of corn syrup is 
proprietary information) may positively impact on its’ repeatability. Further, it has been 
suggested that the glucose could be substituted for grain or sweet feed, which may further 
increase the popularity and uptake of the test [71]. However, more research in this area is 
required. 
 
Diagnosis of insulin dysregulation 
Combination of tests 
The diagnosis of insulin dysregulation can be achieved by demonstration of tissue insulin 
resistance or hyperinsulinaemia (basal or after evocative testing). It appears that some horses 
develop tissue insulin resistance in the absence of compensatory hyperinsulinaemia (decreased 
peripheral tissue uptake), and others can develop transient hyperinsulinaemia in the absence of 
tissue insulin resistance (inappropriate intestinal absorption effect), while some horses develop 
both hyperinsulinaemia and tissue insulin resistance [11]. The problem with current tests is 
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that they only investigate one arm of the disease and therefore may lack sensitivity and fail to 
diagnose patients that would benefit from earlier therapeutic measures. Additionally, since the 
intrinsic value of the different tests described in this review are often calculated based on the 
results of the EHC or the modified FSIGTT, it is possible that the apparent low sensitivity of 
some tests is explained by the fact that the tests were not investigating the same arm of insulin 
dysregulation [40; 45]. Therefore, it may be recommended that the diagnosis of insulin 
dysregulation be done in a stepwise manner, starting with baseline values of insulin and glucose 
and finishing with a combination of tests that diagnose tissue insulin resistance as well as tests 
that assess the enteroinsular axis. 
 
Incretins 
With a better understanding of insulin dysregulation, new targets, beyond insulin and glucose, 
have been studied to facilitate early diagnosis. Studies from the human literature have 
demonstrated the role that incretins released by the intestine after carbohydrate ingestion play 
in stimulating the release of insulin, and this effect has now also been demonstrated in horses 
[11; 72]. The two principal incretins, glucagon-like peptide-1 (GLP-1) and glucose-dependent 
insulinotropic peptide (GIP, previously gastric inhibitory peptide) have been investigated in 
horses [11; 73]. GLP-1 is secreted by pancreatic L cells after ingestion of carbohydrate and 
increases glucose-stimulated insulin secretion by pancreatic  cells [74]. Plasma GLP-1 has been 
shown to strongly correlate with insulin secretion in horses [11; 73; 75]. However, in one study, 
GLP-1 plasma concentrations did not differ between control horses and horses diagnosed with 
EMS, even when horses with EMS were fed a diet rich in carbohydrates [73]. In other studies, 
horse/ponies diagnosed as insulin dysregulated on the results of an OGT had a significant 
increase in post-glucose GLP-1 [11; 73; 75]. The role of GIP has been investigated less 
frequently in horses but it is also secreted after the ingestion of carbohydrates. It appears to be 
secreted in larger amounts overall; however, no difference in plasma GIP was found following a 
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dose of oral glucose in control ponies and ponies diagnosed as insulin dysregulated using an 
OGT [11]. The stimulation of post-prandial insulin secretion by incretins is important, as this 
pathway may be a potential target for the treatment of EMS. However, the incretin effect 
appears to be smaller in horses than in humans, with glucose remaining the primary stimulus 
for insulin release [11]. 
 
C peptide 
Proinsulin is cleaved into C peptide and insulin and, unlike insulin, C peptide does not undergo 
first-passage through the liver increasing its half-life to six times that of insulin [76]. In horses, 
it has been shown that exaggerated insulin responses to an OGT also result in significantly 
elevated C peptide concentrations suggesting that C peptide could be used to assess pancreatic 
secretion and dysfunction in this species [77; 78]. 
 
Adiponectin 
Adiponectin is an anti-inflammatory cytokine produced by adipocytes that has a role in glucose 
regulation [79]. While two early studies failed to correlate plasma adiponectin with insulin, 
even after intravenous or oral glucose challenges [80; 81], more recent studies have 
demonstrated that plasma adiponectin could be more useful than initially expected [3; 82]. 
Adiponectin concentration and body mass index are negatively correlated in horses [83]. It has 
also been shown that feeding horses a diet high in carbohydrates further decreases plasma 
adiponectin compared to feeding horses an isocaloric diet high in fat [82], which demonstrates 
that diet can be more important than body weight in lowering plasma adiponectin 
concentration [82]. Additionally, in a study looking at horses with no previous history of 
laminitis, a plasma adiponectin concentration <2.5 µg/mL was found to have a sensitivity and a 
specificity of 80% to predict the occurrence of pasture-associated laminitis within 3 years [3]. 
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In that study, there was no correlation between morphometric markers and plasma 
adiponectin, suggesting that adiponectin could be valuable in the diagnosis of insulin 
dysregulation beyond obesity. To date, studies have reported values for both total and high 
molecular weight adiponectin using a number of different assay types. More recent data 
suggests that measurement of high molecular weight adiponectin is more relevant with respect 
to the identification of laminitis risk [3; 82]. 
 
Leptin 
In some studies, leptin has been associated with decreased insulin sensitivity [41; 60; 84]. 
However, rather than insulin sensitivity, increased leptin may be associated with increased 
body condition score [83]. Nevertheless, a leptin concentration of >7.3 ng/mL has been shown 
to have a sensitivity of 63 – 83% in predicting the occurrence of laminitis [85]. 
 
Triglycerides 
Hypertriglyceridaemia has been reported to be a component of EMS in horses, and therefore a 
risk factor for laminitis [2; 60; 86; 87]. However, more recent data show that not all obese 
horses have EMS and that a metabolically healthy, obese state can exist [88]. As serum 
triglyceride concentration is often correlated with body condition score, triglycerides may not 
be a very specific marker of insulin dysregulation and therefore not a valuable predictor of 
laminitis [3; 89]. 
Morphometric markers 
The physical appearance of the horse has been associated with insulin dysregulation and 
extensive research had been undertaken to elaborate an equine body condition score [90]. In 
several studies, an increased body condition score or an increased cresty neck score have been 
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found to correlate with metabolic status and the occurrence of laminitis [22; 84; 86; 91-94]. In a 
study by Carter et al., a body condition score >7/9 had a sensitivity of 100% and a specificity of 
29 – 44% to predict laminitis whereas a cresty neck score >4 had a sensitivity of 50 – 83% and a 
specificity of 78 – 80% to predict laminitis [85]. The relatively low sensitivity and specificity of 
these tests confirms the clinical findings that some obese horses do not have insulin 
dysregulation and some lean horses can have severely insulin dysregulation and contrary to 
what has been thought for a long time, increased body condition score may not alter insulin 
regulation per se. In a recent study by Bamford et al., horses that gained weight on a high fat diet 
did not show any decrease in insulin sensitivity whereas horses that gained weight on a 
carbohydrate diet did, suggesting that the type of diet fed to horses to obtain a significant 
weight gain is more important than the weight itself [82]. 
 
Confounding factors 
Beyond the obvious variability induced by the assay used to measure glucose, insulin or other 
metabolites, the interpretation of different tests may also be altered by horse-related and 
environmental factors. 
 
Horse factors 
The main factor of variability during testing is the horse itself. In almost all studies, there is a 
significant effect of the individual with frequent outliers limiting the generalisation of the data 
and underlying the importance of monitoring horses with equivocal results [66; 69; 75; 95]. 
Another factor of variation, as described above with the EHC, is breed [35]. A significant effect of 
breed was observed for insulin and GLP-1 responses to either an OGT or a modified FSIGTT 
with ponies and Andalusian horses showing greater evidence of insulin dysregulation than 
Standardbred horses [51; 75]. It is anticipated that more breed-associated specificities will be 
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discovered as genome-wide association studies help to establish a genetic basis for insulin 
dysregulation [96]. Finally, conflicting evidence regarding age and the association of ageing with 
hyperinsulinaemia, which may increase the likelihood of older animals developing laminitis, 
suggests that more research is needed before considering the adaptation of reference ranges 
[18; 60; 82]. 
 
Environmental factors 
Several studies have found seasonal variation in the evaluation of insulin dysregulation, with 
spring and autumn being times of relatively poor insulin regulation [66; 95; 97]. Beyond the 
increased non-structural carbohydrate content in grass during these seasons, that might explain 
relative hyperinsulinaemia, the potential relationship between EMS and pituitary pars 
intermedia dysfunction (which is also seasonally affected) may warrant further research, 
especially in older horses [2]. The effect of diet is also amplified by a circadian rhythm as the 
same diet fed in the morning or in the evening did not have the same effect on the GLP-1 
response [75]. Another important factor of variability during testing for insulin dysregulation is 
the fed state of the horse. In fasted horses, a resting insulin >20 µIU/mL is suggestive of insulin 
dysregulation whereas in fed conditions, a resting insulin >60 IU/mL would be suggestive of 
insulin dysregulation [59]. Similarly, for the OST, different results are to be expected whether 
the horse is fasted or fed. In a fed horse, a serum insulin >51 µIU/mL between 30 and 60 min 
post corn syrup is suggestive of insulin dysregulation whereas in a fasted horse, serum insulin 
>60 µIU/mL between 60 and 90 min post corn syrup is suggestive of insulin dysregulation [68]. 
In the short IST, it has been shown that fasted horses were at an increased likelihood of being 
diagnosed as insulin resistant [29]. Fasting may not always be practical and other 
environmental factors are frequently beyond the control of the clinician so the interpretation of 
results needs to be undertaken in an informed manner.  
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Conclusions 
There are still many questions to be answered about the pathophysiology of insulin 
dysregulation in horses, and its links to laminitis. Hopefully, recent advances in the 
understanding of the biology of the equine enteroinsular axis, as well as the initiation of large 
scale studies investigating the genetic basis for insulin dysregulation, will improve our 
diagnostic capabilities and improve the detection of horses at risk before their first episode of 
laminitis. 
 
There is mounting evidence that the diagnosis of insulin dysregulation should include an 
investigation of both tissue insulin resistance and the enteroinsular axis. Regardless of the tests 
used, clinicians should be aware of the potential for test failure or confounding factors and, in 
cases with equivocal results, the repetition of the same test or initiation of another test may be 
warranted. 
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